1094 related articles for article (PubMed ID: 20006859)
1. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
[TBL] [Abstract][Full Text] [Related]
2. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
4. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
5. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
7. Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.
Shakir NA; George AK; Siddiqui MM; Rothwax JT; Rais-Bahrami S; Stamatakis L; Su D; Okoro C; Raskolnikov D; Walton-Diaz A; Simon R; Turkbey B; Choyke PL; Merino MJ; Wood BJ; Pinto PA
J Urol; 2014 Dec; 192(6):1642-8. PubMed ID: 25117476
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates.
de Gorski A; Rouprêt M; Peyronnet B; Le Cossec C; Granger B; Comperat E; Cussenot O; Renard-Penna R; Mozer P
J Urol; 2015 Sep; 194(3):669-73. PubMed ID: 25784374
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination.
Javali TD; Dwivedi DK; Kumar R; Jagannathan NR; Thulkar S; Dinda AK
Int J Urol; 2014 Mar; 21(3):257-62. PubMed ID: 23980749
[TBL] [Abstract][Full Text] [Related]
10. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.
Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C
J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832
[TBL] [Abstract][Full Text] [Related]
11. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
[TBL] [Abstract][Full Text] [Related]
12. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
[TBL] [Abstract][Full Text] [Related]
13. Risk of Prostate Cancer after a Negative Magnetic Resonance Imaging Guided Biopsy.
Kinnaird A; Sharma V; Chuang R; Priester A; Tran E; Barsa DE; Delfin M; Kwan L; Sisk A; Felker E; Marks LS
J Urol; 2020 Dec; 204(6):1180-1186. PubMed ID: 32614257
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.
Filson CP; Natarajan S; Margolis DJ; Huang J; Lieu P; Dorey FJ; Reiter RE; Marks LS
Cancer; 2016 Mar; 122(6):884-92. PubMed ID: 26749141
[TBL] [Abstract][Full Text] [Related]
15. A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion.
Hadaschik BA; Kuru TH; Tulea C; Rieker P; Popeneciu IV; Simpfendörfer T; Huber J; Zogal P; Teber D; Pahernik S; Roethke M; Zamecnik P; Roth W; Sakas G; Schlemmer HP; Hohenfellner M
J Urol; 2011 Dec; 186(6):2214-20. PubMed ID: 22014798
[TBL] [Abstract][Full Text] [Related]
16. Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study.
Arsov C; Quentin M; Rabenalt R; Antoch G; Albers P; Blondin D
Anticancer Res; 2012 Mar; 32(3):1087-92. PubMed ID: 22399637
[TBL] [Abstract][Full Text] [Related]
17. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
[TBL] [Abstract][Full Text] [Related]
19. The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction.
Distler FA; Radtke JP; Bonekamp D; Kesch C; Schlemmer HP; Wieczorek K; Kirchner M; Pahernik S; Hohenfellner M; Hadaschik BA
J Urol; 2017 Sep; 198(3):575-582. PubMed ID: 28373135
[TBL] [Abstract][Full Text] [Related]
20. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.
Hoeks CM; Schouten MG; Bomers JG; Hoogendoorn SP; Hulsbergen-van de Kaa CA; Hambrock T; Vergunst H; Sedelaar JP; Fütterer JJ; Barentsz JO
Eur Urol; 2012 Nov; 62(5):902-9. PubMed ID: 22325447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
